Nearly 90K bottles of Children’s Ibuprofen Oral Suspension recalled nationwide after complaints of ‘gel-like mass’
A nationwide recall has been issued for a children’s pain reliever due to reports of foreign material found in the product, according to federal regulators.
Approximately 90,000 bottles of Children’s Ibuprofen Oral Suspension have been recalled after consumers discovered a “gel-like mass and black particles” inside the medication, as stated in an enforcement report issued by the Food and Drug Administration.
The liquid ibuprofen, produced in India, was manufactured for Taro Pharmaceuticals USA, Inc. and distributed throughout the United States, according to regulators.
The recall was initiated by Strides Pharma Inc., a company based in New Jersey, on March 2 and is still ongoing.
The affected medication is administered in doses of 100 milligrams per teaspoon and is available in 4-ounce bottles.
The impacted lots are 7261973A and 7261974A, with an expiration date of Jan. 31, 2027.
According to federal officials, the recall is classified as a Class II recall, indicating that the product may cause temporary or medically reversible health issues with a low risk of injury or death.
The company decided to recall the product voluntarily after receiving complaints about foreign material found in the bottles. The FDA’s enforcement report does not specify the number of complaints received or mention any injuries.
The Post has reached out to Strides Pharma and Taro Pharmaceuticals USA for comments.
90K bottles Childrens complaints gellike Ibuprofen mass nationwide Oral recalled suspension
